绝经在女性心血管疾病发生发展中的作用综述
本文综述绝经过渡期女性心血管疾病风险变化,讨论激素水平下降与动脉僵硬度、内皮功能、脂代谢、胰岛素抵抗和脂肪分布等改变的关系。文章还评估绝经激素治疗的争议性证据,并提出通过早期识别危险因素、提高专业与公众意识来改善女性心血管健康的整体策略。
要点
- 绝经过渡期女性心血管风险谱变化涉及动脉僵硬度、内皮功能、脂代谢、胰岛素抵抗和脂肪分布等多因素。
- 绝经激素治疗对降低心血管疾病风险的作用存在矛盾证据,部分试验报告心血管事件增加。
- 现行心血管风险评分未纳入性别特异性危险因素,指南已开始重视女性生育史。
核心结论
- 心血管疾病是女性最常见的死亡原因,绝经过渡期可能与中年女性心血管疾病患病率相关。
- 提高医疗专业人员和公众对绝经过渡期女性心血管风险增高的认识是改善女性心血管健康的关键方向。
研究设计与样本
- 本文为叙述性综述,讨论绝经女性传统与性别特异性心血管危险因素、绝经激素治疗现行指南、知识空白及降低女性心血管疾病的策略。
主要发现
- 医生常忽视女性心血管疾病危险因素的早期识别,导致诊断和治疗延迟,进而增加发病率和死亡率。
- 绝经过渡期女性心血管风险谱改变包括动脉僵硬度、内皮功能、脂代谢、胰岛素抵抗和脂肪分布变化。
- 部分临床试验报告绝经激素治疗与心血管事件增加相关,现有证据结果相互矛盾。
- 现行心血管风险评估评分未纳入性别特异性危险因素,部分指南和国家卫生系统已开始纳入生育史信息。
关键数值与推荐
- 对绝经过渡期女性应采用整体管理方法,包括个体化危险因素早期识别,以及提高公众和专业人员的风险意识。
临床怎么用
- 对绝经过渡期女性应早期识别个体患者危险因素,并提升公众和专业领域对该人群心血管风险负担的认识。
- 提高医疗专业人员和公众对绝经过渡期女性心血管风险增高的认知,是改善女性心血管健康的关键目标领域。
局限性
- 绝经激素治疗的临床试验证据不一致,部分试验报告心血管事件增加,尚无统一结论。
- 现行心血管风险评分缺乏性别特异性因素,相关指南对生育史的纳入仍处于起步阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular disease (CVD) is the most common cause of death in women. Early identification of CVD risk factors in women is often overlooked by physicians leading to delays in diagnosis and treatment of CVD with subsequent morbidity and mortality. There may be a correlation between declining hormone levels during menopause and the prevalence of CVD during midlife. Alterations in the CVD risk profile of women throughout the menopause transition (MT) are multifactorial and include changes to arterial stiffness, endothelial function, lipid metabolism, insulin resistance and adipose fat distribution. Menopausal Hormonal Therapy (THM) is a potential therapy to reduce CVD risk, though clinical trials have shown conflicting results, with some trials reporting an increase in CVD events with THM. A holistic approach to care for women going through the MT could be beneficial to improve their CVD risk profile and quality of life. This would include early identification of risk factors in individual patients and raising public and professional awareness of CVD risk burden in this patient population. Improving the knowledge of healthcare professionals and the public that women going through the MT are at an increased risk of CVD is a key target area to improve cardiovascular health in women. Current risk assessment scores for CVD do not include sex-specific risk factors. Guidelines and National Health Systems are beginning to recognise the importance of reproductive history in women’s cardiovascular health. In this review, we aim to discuss traditional and sex specific risk factors for CVD in menopausal women, current guidelines on THM, gaps in knowledge and strategies to reduce CVD in women.
引用
- Open Heart:Role of menopause in the development of cardiovascular disease in women
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。